Learning to beat cancer pain: new program shows promise

NCT ID NCT03297723

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a patient education program for 167 cancer patients with moderate to severe pain. The program included identifying patient needs, setting goals, and tailored learning activities. Researchers measured whether the program reduced how much pain interfered with daily life, comparing it to standard care.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
patient therapeutic education program
What this could lead to
If successful, this program could become a standard way to help cancer patients manage pain and improve their quality of life.
What could go wrong
This is a completed study with 167 participants, so results are limited. The program may not work for everyone, and benefits depend on patient engagement and training quality.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cancer Cancer Pain

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • CHU CAEN

    Caen, France

  • Centre François Baclesse

    Caen, France

  • Centre Hospitalier AVRANCHES-GRANVILLE

    Avranches, France

  • Centre Hospitalier Bayeux

    Bayeux, France

  • Centre Hospitalier Lisieux

    Lisieux, France

  • Centre Hospitalier d'Argentan

    Argentan, France

  • Centre Hospitalier de Cherbourg

    Cherbourg-Octeville, France

  • Centre Hospitalier de Flers

    Flers, France

  • Centre Hospitalier de Saint-lo

    Saint-Lô, France

  • Centre Oscar Lambret

    Lille, France

  • Ch Dieppe

    Dieppe, France

  • Ghpso Senlis

    Senlis, France

  • Hopital Européen Georges Pompidou (HEGP)

    Paris, France

  • Hopital privé Paul d'Egine

    Champigny-sur-Marne, France

  • IGR

    Villejuif, France

  • centre Hospitalier d'Alençon

    Alençon, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.